How to Treat EGFR-Mutated Non-Small Cell Lung Cancer

被引：4
|
作者：
Belani, Neel [1 ,4 ]
Liang, Katherine [2 ]
Fradley, Michael [3 ]
Judd, Julia [1 ]
Borghaei, Hossein [1 ]
机构：
[1] Fox Chase Canc Ctr, Dept Hematol & Oncol, Philadelphia, PA USA
[2] Temple Univ Hlth Syst, Dept Internal Med, Philadelphia, PA USA
[3] Univ Penn, Perelman Sch Med, Cardiooncol Translat Ctr Excellence, Div Cardiol, Philadelphia, PA 19104 USA
[4] Univ Penn, Perelman Sch Med, 333 Cotman Ave, Philadelphia, PA 19111 USA
来源：
JACC: CARDIOONCOLOGY | 2023年 / 5卷 / 04期
关键词：
cardiomyopathy; lung cancer; tyrosine kinase inhibitor; OSIMERTINIB;
D O I：
10.1016/j.jaccao.2023.04.005
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：542 / 545
页数：4
相关论文
共 50 条
  • [21] Plasma Predictive Features in Treating EGFR-Mutated Non-Small Cell Lung Cancer
    Steendam, Christi M. J.
    Veerman, G. D. Marijn
    Pruis, Melinda A.
    Atmodimedjo, Peggy
    Paats, Marthe S.
    van der Leest, Cor
    von der Thusen, Jan H.
    Yick, David C. Y.
    Oomen-de Hoop, Esther
    Koolen, Stijn L. W.
    Dinjens, Winand N. M.
    van Schaik, Ron H. N.
    Mathijssen, Ron H. J.
    Aerts, Joachim G. J. V.
    Dubbink, Hendrikus Jan
    Dingemans, Anne-Marie C.
    CANCERS, 2020, 12 (11) : 1 - 17
  • [22] Plasma metabolite biomarkers for EGFR-mutated non-small cell lung cancer (NSCLC)
    Thamlikitkul, Lucksamon
    Manocheewa, Siriphan
    Limjiasahapong, Suphitcha
    Wanichthanarak, Kwanjeera
    Panya, Atikorn
    Poungvarin, Naravat
    Pomyen, Yotsawat
    Khoomrung, Sakda
    CANCER RESEARCH, 2024, 84 (06)
  • [23] RNA Sequencing to Characterize Pathways in EGFR-mutated Non-Small Cell Lung Cancer
    Yun, N.
    Naqib, A.
    Borgia, J. A.
    Fidler, M. J.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S458 - S459
  • [24] RNA sequencing to characterize pathways in EGFR-mutated non-small cell lung cancer
    Yun, Nicole
    Naqib, Ankur D.
    Borgia, Jeffrey Allen
    Batus, Marta
    Fidler, Mary Jo J.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [25] Progress in individualized treatment for EGFR-mutated advanced non-small cell lung cancer
    Inoue, Akira
    PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES, 2020, 96 (07): : 266 - 272
  • [26] Progression of leptomeningeal metastases in advanced EGFR-mutated non-small cell lung cancer
    Zhao, Q.
    Deng, L.
    Zhang, Y.
    Zhou, X.
    Li, Y.
    Yu, M.
    Zhou, L.
    Zou, B.
    Liu, Y.
    Lu, Y.
    ANNALS OF ONCOLOGY, 2016, 27
  • [27] A Patient With Newly Diagnosed, Advanced EGFR-Mutated Non-Small Cell Lung Cancer
    Lara-Mejia, Luis
    Sanchez-Reyes, Roberto
    Aviles-Salas, Alejandro
    Arrieta-Rodriguez, Oscar
    ONCOLOGY-NEW YORK, 2020, 34 (01): : 21 - 27
  • [28] Treatment in EGFR-mutated non-small cell lung cancer: how to block the receptor and overcome resistance mechanisms
    Proto, Claudia
    Lo Russo, Giuseppe
    Corrao, Giulia
    Ganzinelli, Monica
    Facchinetti, Francesco
    Minari, Roberta
    Tiseo, Marcello
    Garassino, Marina Chiara
    TUMORI JOURNAL, 2017, 103 (04): : 325 - 337
  • [29] Acquired Resistance to Osimertinib in EGFR-Mutated Non-Small Cell Lung Cancer: How Do We Overcome It?
    Bertoli, Elisa
    De Carlo, Elisa
    Del Conte, Alessandro
    Stanzione, Brigida
    Revelant, Alberto
    Fassetta, Kelly
    Spina, Michele
    Bearz, Alessandra
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (13)
  • [30] Rociletinib in EGFR-Mutated Non-Small-Cell Lung Cancer
    Sequist, L. V.
    Soria, J-C
    Goldman, J. W.
    Wakelee, H. A.
    Gadgeel, S. M.
    Varga, A.
    Papadimitrakopoulou, V.
    Solomon, B. J.
    Oxnard, G. R.
    Dziadziuszko, R.
    Aisner, D. L.
    Doebele, R. C.
    Galasso, C.
    Garon, E. B.
    Heist, R. S.
    Logan, J.
    Neal, J. W.
    Mendenhall, M. A.
    Nichols, S.
    Piotrowska, Z.
    Wozniak, A. J.
    Raponi, M.
    Karlovich, C. A.
    Jaw-Tsai, S.
    Isaacson, J.
    Despain, D.
    Matheny, S. L.
    Rolfe, L.
    Allen, A. R.
    Camidge, D. R.
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (18): : 1700 - 1709
12345